I just found this bb and like the quality of the material. Congrats to those who post.
I am not up to speed on FDA approvals of diagnostic drugs and the difference in diagnostic/prognostic approval. In CC it did sound like a diagnostic approval from the FDA was a goal of NEOP. Is this accomplished by setting up a different data set in a trial?
Point me in the right direction if you want me to do my own dd. Thanks
Market Data 
Markets 
AI
